[go: up one dir, main page]

LV10687A - Farmakologiska sastava iegusanas panemiens - Google Patents

Farmakologiska sastava iegusanas panemiens

Info

Publication number
LV10687A
LV10687A LV930585A LV930585A LV10687A LV 10687 A LV10687 A LV 10687A LV 930585 A LV930585 A LV 930585A LV 930585 A LV930585 A LV 930585A LV 10687 A LV10687 A LV 10687A
Authority
LV
Latvia
Prior art keywords
pharmacological composition
composition acquisition
saturation
acquisition saturation
pharmacological
Prior art date
Application number
LV930585A
Other languages
English (en)
Other versions
LV10687B (en
Inventor
Gazdag Maria Dr
Szepesi Gabor Dr
Takacsi Nagy Geza Dr
Zsofia Papp
Laszlo Nagy
Monika Zsoldos
Eva Eszter Kiss
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of LV10687A publication Critical patent/LV10687A/lv
Publication of LV10687B publication Critical patent/LV10687B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Press Drives And Press Lines (AREA)
  • Press-Shaping Or Shaping Using Conveyers (AREA)
  • Powder Metallurgy (AREA)
LVP-93-585A 1989-11-07 1993-06-15 Injectable solutions and process for preparing same LV10687B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU895804A HU204995B (en) 1989-11-07 1989-11-07 Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes

Publications (2)

Publication Number Publication Date
LV10687A true LV10687A (lv) 1995-06-20
LV10687B LV10687B (en) 1995-12-20

Family

ID=10970758

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-585A LV10687B (en) 1989-11-07 1993-06-15 Injectable solutions and process for preparing same

Country Status (37)

Country Link
US (1) US5397784A (lv)
JP (1) JP3042702B2 (lv)
KR (1) KR0164601B1 (lv)
CN (1) CN1053569C (lv)
AR (1) AR245592A1 (lv)
AT (1) AT401469B (lv)
AU (1) AU638504B2 (lv)
BE (1) BE1004051A4 (lv)
BG (1) BG60609B1 (lv)
CA (1) CA2029368C (lv)
CH (1) CH682130A5 (lv)
CZ (1) CZ279433B6 (lv)
DE (1) DE4035253B4 (lv)
DK (1) DK266390A (lv)
ES (1) ES2026062A6 (lv)
FI (1) FI100455B (lv)
FR (1) FR2653998B1 (lv)
GB (1) GB2238241B (lv)
GR (1) GR1001041B (lv)
HU (1) HU204995B (lv)
IE (1) IE62387B1 (lv)
IL (1) IL96249A (lv)
IT (1) IT1242724B (lv)
LT (1) LT3334B (lv)
LV (1) LV10687B (lv)
MY (1) MY104595A (lv)
NL (1) NL9002412A (lv)
NO (1) NO175565C (lv)
NZ (1) NZ236005A (lv)
PL (1) PL164881B1 (lv)
PT (1) PT95810B (lv)
RU (1) RU1828401C (lv)
SE (1) SE509715C2 (lv)
SK (1) SK540290A3 (lv)
UA (1) UA13162A (lv)
YU (1) YU48373B (lv)
ZA (1) ZA908855B (lv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1229934B1 (en) 1999-10-01 2014-03-05 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
JP2002100303A (ja) * 2000-09-20 2002-04-05 Hitachi Ltd カラ−陰極線管
US20050170015A1 (en) * 2000-10-31 2005-08-04 Brown Dennis M. Antiproliferative colchicine compositions and uses thereof
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
US8512761B2 (en) * 2006-01-27 2013-08-20 Yale University Fast acting inhibitor of gastric acid secretion
TWI678213B (zh) * 2015-07-22 2019-12-01 美商史倍壯製藥公司 用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD155034A1 (de) * 1980-07-31 1982-05-12 Uwe Olthoff Verfahren zur herstellung stabiler kalziumhaltiger injektionsloesungen
IT1170152B (it) 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
HU195513B (en) * 1984-10-16 1988-05-30 Richter Gedeon Vegyeszet Process for producing stable solutions of alkaloides with bis-indole skeleton
FR2597750B1 (fr) * 1986-04-25 1989-06-02 Pf Medicament Solution aqueuse stable de sulfate de vincristine
IL83086A (en) * 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions

Also Published As

Publication number Publication date
JPH03206040A (ja) 1991-09-09
CA2029368C (en) 2000-01-04
IT1242724B (it) 1994-05-17
KR0164601B1 (ko) 1999-01-15
AT401469B (de) 1996-09-25
ZA908855B (en) 1991-08-28
GB9024222D0 (en) 1990-12-19
CA2029368A1 (en) 1991-05-08
AU638504B2 (en) 1993-07-01
JP3042702B2 (ja) 2000-05-22
IL96249A0 (en) 1991-08-16
DK266390D0 (da) 1990-11-06
GR1001041B (el) 1993-03-31
GB2238241A (en) 1991-05-29
FI100455B (fi) 1997-12-15
IE62387B1 (en) 1995-01-25
FR2653998B1 (fr) 1995-02-17
SK278421B6 (en) 1997-05-07
GB2238241B (en) 1993-10-06
CH682130A5 (lv) 1993-07-30
LV10687B (en) 1995-12-20
IT9067868A1 (it) 1992-05-06
HU204995B (en) 1992-03-30
GR900100795A (en) 1992-04-17
MY104595A (en) 1994-04-30
BE1004051A4 (fr) 1992-09-15
US5397784A (en) 1995-03-14
DE4035253B4 (de) 2004-10-07
YU209590A (sh) 1993-05-28
NO904821D0 (no) 1990-11-06
SE9003523D0 (sv) 1990-11-06
KR910009245A (ko) 1991-06-28
HU895804D0 (en) 1990-01-28
LT3334B (en) 1995-07-25
DE4035253A1 (de) 1991-05-08
DK266390A (da) 1991-05-08
PL164881B1 (en) 1994-10-31
NO175565C (no) 1994-11-02
NO175565B (no) 1994-07-25
HUT55225A (en) 1991-05-28
PT95810A (pt) 1991-09-13
CZ540290A3 (en) 1994-11-16
AU6584590A (en) 1991-05-16
AR245592A1 (es) 1994-02-28
NL9002412A (nl) 1991-06-03
ES2026062A6 (es) 1992-04-01
IE903993A1 (en) 1991-05-08
SE509715C2 (sv) 1999-03-01
IL96249A (en) 1995-07-31
ATA223090A (de) 1996-02-15
BG60609B1 (bg) 1995-10-31
LTIP512A (en) 1994-11-25
BG93175A (bg) 1993-12-24
YU48373B (sh) 1998-07-10
SK540290A3 (en) 1997-05-07
NO904821L (no) 1991-05-08
CN1053185A (zh) 1991-07-24
CZ279433B6 (cs) 1995-04-12
NZ236005A (en) 1992-03-26
PT95810B (pt) 1997-11-28
SE9003523L (sv) 1991-05-08
FI905508A0 (fi) 1990-11-07
RU1828401C (ru) 1993-07-15
CN1053569C (zh) 2000-06-21
IT9067868A0 (it) 1990-11-06
FR2653998A1 (fr) 1991-05-10
UA13162A (uk) 1997-02-28

Similar Documents

Publication Publication Date Title
BR9006919A (pt) Composicao de rimel
BR9007196A (pt) Composicao
DK68789D0 (da) Injektionspen
SE9000221D0 (sv) Komposition
DK0396968T3 (da) Mejetærsker
ATA156090A (de) Verschlussanordnung
BR8905204A (pt) Composicao colutoria
BR8806982A (pt) Composicao estabilizada
BR8802017A (pt) Composicao estabilizada
DE69025281D1 (de) Polypropylen-Zusammensetzung
DK384889D0 (da) Forbedringer relateret til enzymer
FI913521A7 (fi) Nopea esijaotin
BR9006584A (pt) Composicao de poli-oxi-metileno
ID996B (id) Pirrolum tersubstitusi
BR8906787A (pt) Composicao
NO914160D0 (no) Stabilisert vismutoksid
FI910111A7 (fi) Suihkutettava koostumus
FI903296A7 (fi) VIP-analogit II
LV10687A (lv) Farmakologiska sastava iegusanas panemiens
BR8902491A (pt) Composicao
TR26099A (tr) Islah edilmis pestisid terkip
BR8907528A (pt) Composicao crio-protetora
BR8702288A (pt) Composicao de organoplisiloxana
FI892217A7 (fi) Dendriittiä vastustava koostumus
BR9005424A (pt) Composicao